期刊文献+

哌立福辛抑制胃癌细胞SGC7901增殖及其作用机制

Inhibition of perifosine on proliferation of gastric cancer cell line SGC7901 in vitro
下载PDF
导出
摘要 目的:探讨哌立福辛对体外培养的人胃癌SGC7901细胞生长增殖的影响并探讨其机制。方法:分别用不同浓度的哌立福辛(0.125、0.250、0.500、0.750、1.500μmol/L)对SGC7901细胞进行干预后,采用磺酰罗丹明B(SRB)法检测细胞增殖变化;平板克隆实验检测细胞克隆形成能力;Real-time PCR、Western blot法检测癌症相关基因eIF4E及AEG-1 mRNA及蛋白表达。结果:哌立福辛呈时间及浓度依赖性抑制胃癌SGC7901细胞的增殖,并降低细胞的克隆形成能力;细胞内AKT信号通路中AEG-1、eIF4E的表达明显降低。结论:哌立福辛具有抑制胃癌SGC7901细胞增殖的作用;通过降低AKT信号通路中AEG-1和eIF4E的mRNA及蛋白表达可能是发挥增殖抑制作用的机制之一。 Objective:To investigate the effects of perifosine on the growth of human gastric carcinoma cell line SGC7901.Methods:The inhibitory effect of perifosine on the growth of human gastric cancer cell line SGC7901 was observed at different concentrations(0.125,0.250,0.500,0.750,1.500) μmol/L by sulforhodamine B(SRB)assay.Plate colony formation assay was performed to detect the colony formation rate.The expression levels of eIF4E and AEG-1 were determined by Real-time PCR and Western blot.Results:Perifosine inhibited the growth of gastric cancer cell line SGC7901 in dose-and time-dependent manners.The cell colony formation rate was statistically decreased(P 0.05) as compared with those in the control.The mRNA and protein levels of eIF4E and AEG-1 were reduced gradually dose-dependently.Conclusion:Perifosine,an AKT inhibitor,inhibits the growth and the colony formation rate of human gastric cancer cell via downregulating the expression of eIF4E and AEG-1.
作者 谢海彬 李忠
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2013年第8期1077-1080,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 常州市卫生局重大项目(ZD200906)
关键词 哌立福辛 胃癌 增殖 抑制 perifosine gastric carcinoma proliferation inhibition
  • 相关文献

参考文献13

  • 1Gills JJ, Dennis PA. Perifosine:update on a novel Akt in- hibitor [ J ]. Cnrr Oncol Rep, 2009, 11 (2) : 102-110.
  • 2Chiarini F, Del Sole M,Mongiorgi S,et al. The novel Akt inhibitor,perifosine,induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in mul- tidrug-resistant human T-acute leukemia cells by a JNK- dependent mechanism [J]. Leukemia, 2008,22 (6) : 1106- 1116.
  • 3David E, Sinha R, Chen J, et al. Perifosine synergistically enhances TRAIL-induced myeloma cell apoptosis via up- regulation of death receptors [J]. Clin Cancer Res, 2008,14(16) : 5090-5098.
  • 4Li Z,Tan F,Liewehr DJ,et al. In vitro and in vivo inhibition of neuroblastoma tumor cell growth by AKT inhibitor peri- fosine[J]. J Nat1 Cancer Inst,2010,102(11):758-770.
  • 5Leighl NB, Dent S, Clemons M,et al. A Phase 2 study of perifosine in advanced or metastatic breast cancer [J]. Breast Cancer Res Treat, 2008,108( 1 ) : 87-92.
  • 6Chee KG, Longmate J, Quinn DI, et al. The AKT inhibitor perifosine in biochemically recurrent prostate cancer:a phase II California/Pittsburgh cancer consortium triM[J]. Clin Genitourin Cancer, 2007,5 (7) : 433-437.
  • 7Cho DC,Hutson TE,Samlowski W,et al. Two phase 2 trials of the novel Akt inhibitor perifosine in patients with ad- vanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy [J]. Cancer, 2012, 118 (24) : 6055 -6062.
  • 8Siegel R, Naishadham D,Jemal A. Cancer statistics, 2012 [J]. CA Cancer J Clin,2012,62( 1 ) : 10-29.
  • 9De Luca A,Maiello MR,D'Alessio A,et al. The RAS/ RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeu- tic approaches [J]. Expert Opin Ther Targets,2012,16 (Suppl 2) :S17-27.
  • 10董光辉,罗璇,翟溯澜,李萍,王雪融.哌立福辛通过激活GSK3β抑制雷帕霉素耐药细胞的生长[J].中国临床药理学与治疗学,2011,16(4):389-393. 被引量:3

二级参考文献22

  • 1周星辉,王丙力,谭焕然.大鼠肝实质细胞原代培养模型的研究及其功能鉴定[J].中国临床药理学与治疗学,2005,10(7):743-746. 被引量:9
  • 2Liang J, Slingerland JM. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression [J]. Cell Cycle,2003,2(4): 339-345.
  • 3Fu L, Kim YA, Wang X, et al. Perifosine inhibits mammalian target of Rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy[J]. Cancer Res, 2009,69(23): 8967-8976.
  • 4Abraham RT, Gibbons JJ. The mammalian target of Rapamycin signaling pathway: twists and turns in the road to cancer therapy[J]. Clin Cancer Res, 2007,13(11): 3109-3114.
  • 5Sun SY, Rosenberg LM, Wang X, et al. Activation of Akt and eIF4E survival pathways by Rapamyeinmediated mammalian target of Rapamycin inhibition [J]. Cancer Res,2005,65(16):7052-7058.
  • 6THONGPRASERT S. The role of prostatic carcinoma [J]. Ann Oncol, 2005, 16(2): 93-96.
  • 7CHO1 CW, CHOI IK, SEO JH, et al. Effects of 5-fluororacil and leucovorin in the treatment of gastric carcinoma [J]. Am J Clin Oncol, 2000, 23(4): 425-428.
  • 8JIMENEZ-LOPEZ JM, RIOS-MARCO P, MARCO C. et al. Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids[J]. Lipids Health Dis, 2010, 9: 33.
  • 9HIDESH1MA T, CATLEY L, RAJE N, et al. Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cells [J]. Br J Haematol, 2007, 138: 783-791.
  • 10LI Z, TAN F, LIEWEHR D J, et al. In vitro and in vivo inhibition of neuroblastoma tumor cell growth by AKT inhibitor perifosine[J]. Journal of the National Cancer Institute, 2010, 102(11): 758-770.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部